Acadia Pharmaceuticals (ACAD) Interest Coverage Ratio (2011 - 2026)

Acadia Pharmaceuticals' Interest Coverage Ratio history runs 16 years deep, the most recent figure standing at 0.78 for Q1 2026.

• On a quarterly basis, Interest Coverage Ratio fell 358.82% year-over-year to 0.78 in Q1 2026; TTM through Mar 2026 was 13.68, a 272.57% increase from a year earlier, with the FY2025 full-year figure at 1.32, down 87.9% from the prior year.
• Interest Coverage Ratio declined to 0.78 in Q1 2026 per ACAD's latest filing, from 5.45 in the prior quarter.
• Across five years, Interest Coverage Ratio topped out at 59.64 in Q4 2024 and bottomed at 19.51 in Q4 2022.
• The 5-year median for Interest Coverage Ratio is 0.3 (2025), against an average of 3.33.
• Across the five-year window, Interest Coverage Ratio tumbled 1697.47% in 2022 and surged 6853.33% in 2024, its largest moves.
• Year by year, Interest Coverage Ratio stood at 19.51 in 2022, then surged by 174.82% to 14.6 in 2023, then jumped by 308.56% to 59.64 in 2024, then sank by 90.87% to 5.45 in 2025, then plunged by 114.33% to 0.78 in 2026.
• Per Business Quant, the three latest ACAD Interest Coverage Ratio figures stand at 0.78 (Q1 2026), 5.45 (Q4 2025), and 3.13 (Q3 2025).